You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -23,971.4% | -1,527.7% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.3 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 429.2 | 29.1 |
| Price / Book value | 1.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | n/a | -3.02 | -8.42p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-06-30 | n/a | -7.06 | -14.86p | -9.7 | 0.0 | n/a | n/a | 0.0% |
| 2017-06-30 | n/a | -12.15 | -17.83p | -7.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-06-30 | 0.07 | -16.91 | -26.55p | -7.0 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | 1.03 | -15.79 | -21.82p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-06-30 | 2.58 | -14.54 | -14.32p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Diurnal partner submits marketing authorisation for 'Alkindi' in Australia Sharecast News | 03 Jul |
|---|---|
| Diurnal Group launches placing and open offer to fund drug development Sharecast News | 28 May |
| Diurnal gets orphan drug designation for Alkindi in Australia Sharecast News | 24 Apr |
| Director Dealings | 07-Aug-19 11:04 |
|---|---|
| Director/PDMR Shareholding | 05-Aug-19 12:28 |
| Holding(s) in Company | 26-Jul-19 16:33 |
| Director Dealings and Issue of Equity | 08-Jul-19 14:09 |
| Market Authorisation Application in Australia | 03-Jul-19 07:01 |